主要银行上调了Medline股票，理由是强劲的财报和内幕买入，提升了投资者信心。 Major banks upgraded Medline stock, citing strong earnings and insider buys, boosting investor confidence.

包括高盛公司、JP摩根公司和巴克莱公司在内的多个大公司的分析师在Medline(MDLN)上发布了购买或超重评级,提高了投资者的兴趣。 Analysts at multiple major firms, including Goldman Sachs, JPMorgan, and Barclays, have issued buy or overweight ratings on Medline (MDLN), boosting investor interest. 2026年1月15日,该库存开放43.41美元,为期52周,范围为34.89至45.50美元。 The stock opened at $43.41 on January 15, 2026, with a 52-week range of $34.89 to $45.50. 2025年12月18日 Charles N. Mills董事 和Andrew J. On December 18, 2025, Directors Charles N. Mills and Andrew J. 米尔斯各以29美元的价格购买了约250万股，显示出内部人士的信心。 Mills each bought about 2.5 million shares at $29.00, signaling insider confidence. 虽然一些公司,如法国巴黎银行和Rothschild/Redb发行的持有评级,但由于对收入的期待很高,供应链可见度很高,总体情绪仍然积极。 While some firms like BNP Paribas and Rothschild/Redb issued hold ratings, the overall sentiment remains positive due to strong earnings expectations and supply chain visibility. Medline为全国的医疗服务提供者提供医疗产品和物流服务。 Medline supplies medical products and logistics services to healthcare providers nationwide.